Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Utility Study to Determine Impact of PanCystPro Assay on Physician Decision-making in the Management of Pancreatic Cystic Lesions

NCT06894329 is registered in ClinicalTrials.gov with Amplified Sciences Inc as lead sponsor.

NCT NCT06894329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06894329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Utility Study to Determine Impact of PanCystPro Assay on Physician Decision-making in the Management of Pancreatic Cystic Lesions
Lead sponsor
Amplified Sciences Inc
Phase
Observational
Overall status
Recruiting
Start date
February 17, 2026
Completion date
June 30, 2027
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cystic lesions